Cargando…
Type IV collagen is a tumour stroma-derived biomarker for pancreas cancer
BACKGROUND: Pancreas cancer is a dreaded disease with high mortality, despite progress in surgical and oncological treatments in recent years. The field is hampered by a lack of good prognostic and predictive tumour biomarkers to be used during follow-up of patients. METHODS: The circulating level o...
Autores principales: | Öhlund, D, Lundin, C, Ardnor, B, Öman, M, Naredi, P, Sund, M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2713699/ https://www.ncbi.nlm.nih.gov/pubmed/19491897 http://dx.doi.org/10.1038/sj.bjc.6605107 |
Ejemplares similares
-
Quantitative evaluation of vimentin expression in tumour stroma of colorectal cancer
por: Ngan, C Y, et al.
Publicado: (2007) -
Tumour-site-dependent expression profile of angiogenic factors in tumour-associated stroma of primary colorectal cancer and metastases
por: Kahlert, C, et al.
Publicado: (2014) -
High levels of cleaved caspase-3 in colorectal tumour stroma predict good survival
por: Noble, P, et al.
Publicado: (2013) -
Investigating prostate cancer tumour–stroma interactions: clinical and biological insights from an evolutionary game
por: Basanta, D, et al.
Publicado: (2012) -
Expression of the chemokine CXCL14 in the tumour stroma is an independent marker of survival in breast cancer
por: Sjöberg, Elin, et al.
Publicado: (2016)